These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5725 related articles for article (PubMed ID: 4625608)

  • 1. Inhibition of melanoma tyrosinase by fusaric acid.
    Nagatsu T; Sudo I; Okada T; Umezawa H; Takeuchi T
    Experientia; 1972 Jun; 28(6):634. PubMed ID: 4625608
    [No Abstract]   [Full Text] [Related]  

  • 2. Analogues of fusaric (5-butylpicolinic) acid as potent inhibitors of dopamine -hydroxylase.
    Hidaka H; Asano T; Takemoto N
    Mol Pharmacol; 1973 Mar; 9(2):172-7. PubMed ID: 4197141
    [No Abstract]   [Full Text] [Related]  

  • 3. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence and properties of tyrosinase in sera of melanoma-bearing animals.
    Haberman HF; Menon IA
    Acta Derm Venereol; 1971; 51(6):407-12. PubMed ID: 4109420
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of two copper-containing enzymes, tyrosinase and dopamine beta-hydroxylase, by L-mimosine.
    Hashiguchi H; Takahashi H
    Mol Pharmacol; 1977 Mar; 13(2):362-7. PubMed ID: 404519
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory mechanisms of tyrosinase activity in melanocyte. I.
    Seiji M; Fukuzawa H; Miyazaki N; Akiba H; Kato T
    Yale J Biol Med; 1973 Dec; 46(5):508-15. PubMed ID: 4205118
    [No Abstract]   [Full Text] [Related]  

  • 7. Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
    Hamada T; Mishima Y
    Br J Dermatol; 1972 Apr; 86(4):385-94. PubMed ID: 4623455
    [No Abstract]   [Full Text] [Related]  

  • 8. Non-premelanosomal and premelanosomal tyrosinase activity in Greene's amelanotic and melanotic malignant melanoma.
    Mishima Y; Adams JF
    Cancer; 1969 Apr; 23(4):952-7. PubMed ID: 4975667
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of dopamine-beta-hydroxylase inhibitors 1,1-dimethyl-3-phenyl-2-thiourea, fusaric acid and dimethyldithiocarbamate, on the rat brain monoamine content following intraventricular injection of L-dopa.
    Vetulani J; Reichenberg K
    Biochem Pharmacol; 1973 Jun; 22(11):1263-8. PubMed ID: 4727781
    [No Abstract]   [Full Text] [Related]  

  • 10. Inactivation mechanism of tyrosinase.
    Shimao K; Seiji M; Fukuzawa H
    Tohoku J Exp Med; 1974 Nov; 114(3):263-72. PubMed ID: 4218379
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of phenothiazines on melanoma tyrosinase activity.
    Van Woert MH
    J Pharmacol Exp Ther; 1970 Jun; 173(2):256-64. PubMed ID: 4988494
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of human serum dopamine -hydroxylase after the oral administration of fusaric acid.
    Nagatsu T; Kato T; Kuzuya H; Okada T; Umezawa H; Takeuchi T
    Experientia; 1972 Jul; 28(7):779-80. PubMed ID: 4658852
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter: Fusaric acid derivatives: the effect on dopamine beta-hydroxylase.
    Umezawa H; Takeuchi T; Miyano K; Koshigoe K; Hamano H
    J Antibiot (Tokyo); 1973 Mar; 26(3):189. PubMed ID: 4205877
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective suppression of rapid eye movement sleep (REM) by fusaric acid, an inhibitor of dopamine- -oxidase.
    Sato T; Tanaka R
    Experientia; 1973 Feb; 29(2):177-8. PubMed ID: 4348192
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo inhibition of the tyrosinase of hamster melanoma with sodium diethyldithiocarbamate.
    Blagoeva P; Stoichev I
    Experientia; 1979 Oct; 35(10):1389-90. PubMed ID: 227716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proceedings: Effect of a dopamine-beta-hydroxylase inhibitor (fusaric acid) on thyroid hormones and TSH].
    Yoshimura M; Yatani T; Ochi Y; Nagasaka A; Takeda A
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):88. PubMed ID: 4476662
    [No Abstract]   [Full Text] [Related]  

  • 17. Melanization and tyrosinase activity.
    Seiji M; Miyazaki K
    J Invest Dermatol; 1971 Nov; 57(5):316-22. PubMed ID: 5001257
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for a peripheral effect of fusaric acid, a dopamine beta-hydroxylase inhibitor, on serotonin metabolism.
    Bonnay MM; Guerinot F; Bohuon CJ
    Biochem Pharmacol; 1974 Oct; 23(19):2770-3. PubMed ID: 4419680
    [No Abstract]   [Full Text] [Related]  

  • 19. Tyrosinase isolated from mouse melanoma melanosome.
    Miyazaki K; Seiji M
    J Invest Dermatol; 1971 Aug; 57(2):81-6. PubMed ID: 4999637
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of substituted DL-3(5-benzazolyl)alanines as dopa and alpha-methyldopa analogs and their effects on dopamine beta-hydroxylase, tyrosinase and diphenoloxidase.
    Loriga M; Paglietti G; Sparatore F; Pinna G; Sisini A
    Farmaco; 1992 Apr; 47(4):439-48. PubMed ID: 1388592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 287.